239 related articles for article (PubMed ID: 23557017)
21. Unsettling drug patent settlements: a framework for presumptive illegality.
Carrier MA
Mich Law Rev; 2009 Oct; 108(1):37-80. PubMed ID: 20535881
[TBL] [Abstract][Full Text] [Related]
22. International experiences of promoting generics use and its implications to China.
Sun J
J Evid Based Med; 2013 May; 6(2):74-80. PubMed ID: 23829799
[TBL] [Abstract][Full Text] [Related]
23. Productive university, industry, and government relationships in preclinical drug discovery and development: considerations toward a synergistic lingua franca.
Janero DR
Expert Opin Drug Discov; 2012 Jun; 7(6):449-56. PubMed ID: 22540843
[TBL] [Abstract][Full Text] [Related]
24. Policy making on data exclusivity in the European Union: from industrial interests to legal realities.
Adamini S; Maarse H; Versluis E; Light DW
J Health Polit Policy Law; 2009 Dec; 34(6):979-1010. PubMed ID: 20018988
[TBL] [Abstract][Full Text] [Related]
25. Pharmaceutical companies' variation of drug prices within and among countries can improve long-term social well-being.
Lichtenberg FR
Health Aff (Millwood); 2011 Aug; 30(8):1539-44. PubMed ID: 21821571
[TBL] [Abstract][Full Text] [Related]
26. Model-based drug development: a rational approach to efficiently accelerate drug development.
Milligan PA; Brown MJ; Marchant B; Martin SW; van der Graaf PH; Benson N; Nucci G; Nichols DJ; Boyd RA; Mandema JW; Krishnaswami S; Zwillich S; Gruben D; Anziano RJ; Stock TC; Lalonde RL
Clin Pharmacol Ther; 2013 Jun; 93(6):502-14. PubMed ID: 23588322
[TBL] [Abstract][Full Text] [Related]
27. Drug discovery in pharmaceutical industry: productivity challenges and trends.
Khanna I
Drug Discov Today; 2012 Oct; 17(19-20):1088-102. PubMed ID: 22627006
[TBL] [Abstract][Full Text] [Related]
28. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
Federsel HJ
Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405
[TBL] [Abstract][Full Text] [Related]
29. How should we support pharmaceutical innovation?
Grootendorst P
Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
[TBL] [Abstract][Full Text] [Related]
30. Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
Scattereggia J
IDrugs; 2010 Jan; 13(1):26-9. PubMed ID: 20024844
[TBL] [Abstract][Full Text] [Related]
31. The epiphany of data warehousing technologies in the pharmaceutical industry.
Barrett JS; Koprowski SP
Int J Clin Pharmacol Ther; 2002 Mar; 40(3):S3-13. PubMed ID: 11911607
[TBL] [Abstract][Full Text] [Related]
32. A measure of productivity and innovation in the pharmaceutical industry 2011-2015.
Harrison R
Drugs Today (Barc); 2016 Nov; 52(11):627-633. PubMed ID: 28112281
[TBL] [Abstract][Full Text] [Related]
33. The effect of generic competition on the price of brand-name drugs.
Lexchin J
Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
[TBL] [Abstract][Full Text] [Related]
34. Generics market in Greece: the pharmaceutical industry's beliefs.
Geitona M; Zavras D; Hatzikou M; Kyriopoulos J
Health Policy; 2006 Nov; 79(1):35-48. PubMed ID: 16386326
[TBL] [Abstract][Full Text] [Related]
35. Are we living in the end of the blockbuster drug era?
Debnath B; Al-Mawsawi LQ; Neamati N
Drug News Perspect; 2010 Dec; 23(10):670-84. PubMed ID: 21180653
[TBL] [Abstract][Full Text] [Related]
36. Ask the experts: the challenges and benefits of flow chemistry to optimize drug development.
Anderson N; Gernaey KV; Jamison TF; Kircher M; Wiles C; Leadbeater NE; Sandford G; Richardson P
Future Med Chem; 2012 Sep; 4(14):1779-89. PubMed ID: 23043475
[TBL] [Abstract][Full Text] [Related]
37. Inadequately met needs.
Nat Biotechnol; 2011 May; 29(5):371. PubMed ID: 21552219
[No Abstract] [Full Text] [Related]
38. New models for pharmaceutical innovation in low-income countries.
Ardal C; Iversen JH; Myhr K
Tidsskr Nor Laegeforen; 2011 Oct; 131(20):2016-8. PubMed ID: 22016131
[No Abstract] [Full Text] [Related]
39. [AIDS and social justice: pharmaceutical industry and economics].
López Guzmán J
Cuad Bioet; 2008; 19(67):563-74. PubMed ID: 19166259
[TBL] [Abstract][Full Text] [Related]
40. How to revive breakthrough innovation in the pharmaceutical industry.
Munos BH; Chin WW
Sci Transl Med; 2011 Jun; 3(89):89cm16. PubMed ID: 21715677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
